United Arab Emirates

UAE generic drugmaker Julphar has revealed that its 2009 sales reached US$207mn, 21.9% higher than in 2008. The firm is confident it can continue on this upward trajectory and is... 2010-02-04

The Gulf Cooperation Council (GCC) region's pharmaceutical market will be worth US$7.6bn by 2014 and US$9.6bn by 2019. The largest market by value will still be Saudi Arabia, contributing... 2010-02-02

Drug prices in the UAE have been criticised for being up to 23 times higher than World Health Organisation (WHO)-recommended international prices. Despite being part of the Gulf Co-operation... 2010-01-27

The Dubai Biotechnology and Life Sciences Park, DuBiotech, has revealed that an additional 20 firms are expected to open sites in the complex in 2010, highlighting its ongoing investment... 2010-01-26

The UAE government plans to ban the re-export of medicines in order to prevent unintentional trade of counterfeit drugs between Europe and other destinations via the UAE. BMI expect... 2009-12-17

Investments worth US$150mn have been set aside for the construction of a new biotechnology plant in Abu Dhabi. The new facility will be expected to produce and export biologic products... 2009-11-24

Healthcare sector advertising in the Gulf Co-operation Council (GCC) region during January-September 2009 was worth approximately US$162mn, according to the findings of UAE-based... 2009-11-18